Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (575), Orthostatic Hypotension
...CenterWatch: New Medical Therapies in Disease Category (575), Orthostatic Hypotension Orthostatic Hypotension Patient Medical Areas • Cardiology/Vascular Diseases • Neurology November 10, 2008 Chelsea Therapeutics reported positive interim ...
View Page

2.  Newly Approved Drug Therapies (119) ProAmatine (midodrine), Roberts Pharmaceutical,
...presentations. Drug Name: ProAmatine (midodrine) Company: Roberts Pharmaceutical Approval Status: Approved September 1996 Treatment Area: hypotension General Information ProAmatine has been approved for the treatment of hypotension. Additional Information Hypotension is a low blood pressure condition characterized by a sudden drop in ...
View Page

3.  Study Posting (77) Trial #137285, Vascular Diseases, Manhasset, NY
...Study Posting (77) Trial #137285, Vascular Diseases, Manhasset, NY Trial Information Symptomatic Neurogenic Orthostatic Hypotension (NOH) The purpose of this study is to see if the study drug can relieve ...
...no cost. To qualify, you must: • Be at least 18 years old • Diagnosed with orthostatic hypotension You will not qualify if you: • Are pregnant or breast-feeding • Taking ephedrine or midodrine ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (353), Dizzy/Fainting Spells
...interim data from a phase III trial of droxidopa for the treatment of neurogenic orthostatic hypotension (NOH). This randomized, placebo-controlled, induction-design, four-week trial planned to enroll 118 subjects ...
...clear improvement across all doses of Droxidopa up to 600 mg tid. The average Orthostatic Hypotension Symptom Assessment Scale (OHSA) baseline score for responders prior to treatment was 6.4 and ...
View Page

5.  Newly Approved Drug Therapies (298) Cardizem (R) (Diltiazem HC1 for injection) Monvial (R), Hoechst Marion Roussel,
...available beginning in early 1998. Side Effects The most commonly reported adverse events are asymptomatic hypotension (4.3%), symptomatic hypotension (3.2%), injection site reaction (3.9%), flushing (1.7%), and arrhythmia (1.0%). Jobson ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (459), Blood Transfusions
...synthetic substitute for blood transfusions during surgical procedures. Efficacy data indicated significantly lower rates of hypotension in the two Hemospan groups vs. the control group (46%, 42% for low- and high ...
View Page

7.  Newly Approved Drug Therapies (56) Tiazac (diltiazem hydrochloride), Forest Laboratories,
...when blood pressure is at its highest, yet Tiazac achieves blood pressure reduction without causing hypotension during periods of lower blood pressure. Tiazac, a highly concentrated formulation of diltiazem, enables more ...
...mg. Tiazac, as with all diltiazem formulations, should not be used in subjects with severe hypotension (less than 90 mm Hg systolic), acute myocardial infarction and pulmonary congestion documented by x ...
View Page

8.  Newly Approved Drug Therapies (1021) Fanapt (iloperidone), Vanda,
...oral administration. Fanapt must be titrated slowly from a low starting dose to avoid orthostatic hypotension. Usual Dose The recommended starting dose for Fanapt tablets is 1 mg twice daily. Increases ...
...but are not limited to, the following: • Dizziness • Somnolence • Dry Mouth • Nausea • Tachycardia • Diarrhea • Orthostatic Hypotension • Weight Gain Mechanism of Action Fanapt is a psychotropic agent belonging to the chemical class ...
View Page

9.  Newly Approved Drug Therapies (965) Azor (amlodipine besylate; olmesartan medoxomil), Daiichi Sankyo,
...with the use of Azor may include, but are not limited to, the following: • Edema • Hypotension • Orthostatic Hypotension • Rash • Pruritus • Palpitation • Urinary Frequency • Nocturia Mechanism of Action Azor is a combination of the ...
View Page

10.  CenterWatch New Medical Therapies™ in Neurology
...and Cluster Headaches Multiple Sclerosis Muscular Dystrophy Narcolepsy Neurologic Disorders Neuropathy Oral Facial Pain Orthostatic Hypotension Pain Pain (Pediatric) Parkinson's Disease Peripheral Neuropathy Postherpetic Neuralgia Post-Surgical Pain Pregnant women ...
View Page

11.  CenterWatch New Medical Therapies™ in Cardiology/Vascular Diseases
...Preservation and Amputation Men's Health Myocardial Infarction (Heart Attack) Myocardial Ischemia Organ Transplant Orthostatic Hypotension Peripheral Arterial Disease (PAD) Peripheral Arterial Occlusive Disease Peripheral Vascular Disease Smoking Cessation Surgery Thrombosis ...
View Page

12.  Study Posting (3103) Trial #144752, Erectile Dysfunction, Tucson, AZ
...therapy • Penile implant • History of Type 1 or 2 Diabetes • Uncontrolled hypertension or history of hypotension Frances, MA, CRC Quality of Life Medical & Research Center, LLC 5350 E. Erickson Dr Tucson ...
View Page

13.  Newly Approved Drug Therapies (65) Ethyol (amifostine), Alza,
...most common adverse effects of Ethyol were vomiting, low blood pressure, somnolence, and sneezing. Vomiting, hypotension, and somnolence were more common with higher drug doses. In a phase I trial, vomiting ...
View Page

14.  Newly Approved Drug Therapies (120) OxyContin (oxycodone HCl controlled-release), Purdue Pharma,
...or is suspected of having paralytic ileus. OxyContin, like all opioid analgesics, may cause severe hypotension in an individual whose ability to maintain blood pressure has been compromised by a depleted ...
...drugs such as phenothiazines or other agents which compromise vasomotor tone. OxyContin may produce orthostatic hypotension in ambulatory subjects. OxyContin, like all opioid analgesics, should be administered with caution to subjects ...
View Page

15.  Newly Approved Drug Therapies (543) Ethyol (amifostine), U.S. Bioscience, Alza,
...Phase III study included nausea and vomiting which were sometimes severe. Side effects also included hypotension, fever, allergic-type skin reactions, dizziness/lightheadedness, fatigue/lethargy, rigors/chills, sneezing, sleepiness/somnolence, and ...
View Page

16.  CenterWatch: List of Newly Approved Drug Thearapies
...Myers Squibb; Treatment for heart disease, Approved April 1996 ProAmatine (midodrine) ; Roberts Pharmaceutical; Treatment for hypotension, Approved September 1996 Procanbid (procainamide hydrochloride extended-release tablets) ; Warner-Lambert; Treatment for ventricular arrhythmias ...
View Page

17.  Study Posting (4519) Trial #126403, Renal Failure, Shanghai, China
...18-70 years of age; • acute or chronic renal failure or nephrotic syndrome Exclusion Criteria: • hypotension (systolic blood pressure <100 mmHg); • hemodialysis; • end-stage renal failure; • acute diabetic metabolic disorders. Gender ...
View Page

18.  Study Posting (4519) Trial #126439, Renal Failure, Guangzhou, China
...18-70 years of age; • acute or chronic renal failure or nephrotic syndrome Exclusion Criteria: • hypotension (systolic blood pressure <100 mmHg); • hemodialysis; • end-stage renal failure; • acute diabetic metabolic disorders. Gender ...
View Page

19.  Study Posting (4519) Trial #126402, Renal Failure, Beijing, China
...18-70 years of age; • acute or chronic renal failure or nephrotic syndrome Exclusion Criteria: • hypotension (systolic blood pressure <100 mmHg); • hemodialysis; • end-stage renal failure; • acute diabetic metabolic disorders. Gender ...
View Page

20.  Study Posting (1570) Trial #156499, Pediatric Health, Morristown, NJ
...Congenital or acquired gastrointestinal anomalies • Prior episode of necrotizing enterocolitis • Use of inotropic support for hypotension • Renal anomalies or disease • Are receiving > 80 ml/kg/d of enteral feeding Kelly Colucci ...
View Page